Phytogen Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.90 M
as on 03-07-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.54 M
as on 03-07-2024
- Revenue 93.31%
(FY 2018)
- Profit -210.59%
(FY 2018)
- Ebitda -1443.81%
(FY 2018)
- Net Worth -103.85%
(FY 2018)
- Total Assets 3.37%
(FY 2018)
About Phytogen Pharma (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹2.54 M.
Ramesh Mani and Kandan Natarajan serve as directors at the Company.
- CIN/LLPIN
U24232KA2008PTC046106
- Company No.
046106
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2008
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Phytogen Pharma (India) Private Limited offer?
Phytogen Pharma (India) Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Plant Extracts.
Who are the key members and board of directors at Phytogen Pharma (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Mani  | Director | 01-Apr-2019 | Current |
| Kandan Natarajan | Director | 18-May-2009 | Current |
Financial Performance of Phytogen Pharma (India).
Phytogen Pharma (India) Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 93.31% increase. The company also saw a substantial fall in profitability, with a 210.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 103.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phytogen Pharma (India)?
In 2018, Phytogen Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Mar 2012 | ₹2.54 M | Open |
How Many Employees Work at Phytogen Pharma (India)?
Unlock and access historical data on people associated with Phytogen Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phytogen Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phytogen Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
